MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, RPID had $3,038K increase in cash & cash equivalents over the period. -$31,912K in free cash flow.

Cash Flow Overview

Change in Cash
$3,038K
Free Cash flow
-$31,912K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Maturity of investments
    • Proceeds from issuance of debt
    • Accounts receivable
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Purchases of investments
    • Deferred revenue
    • Others

Cash Flow
2025-12-31
Net loss
-47,123
Depreciation and amortization expense
3,252
Noncash interest expense
97
Stock-based compensation expense
4,033
Provision for excess & obsolete inventory
1,143
Noncash lease expense
1,218
Gain on revaluation of warrant liability
-131
Accretion on investments
-351
Other
-34
Accounts receivable
-4,387
Inventory
-1,465
Prepaid expenses and other current assets
-320
Other long-term assets
-64
Accounts payable
1,600
Accrued expenses and other current liabilities
28
Other long-term liabilities
64
Deferred revenue
-1,864
Net cash used in operating activities
-31,062
Purchases of property and equipment
850
Purchases of investments
27,076
Sales of investments
2,505
Maturity of investments
39,750
Net cash provided by investing activities
14,329
Proceeds from issuance of class a common stock - stock option exercise
491
Proceeds from issuance of class a common stock - employee stock purchase plan
162
Proceeds from issuance of debt
20,000
Payments of debt issuance costs
878
Issuance of class a common stock under the atm offering
445
Tax withholding on settlement of restricted stock units
419
Payments on finance lease obligations
30
Net cash provided by financing activities
19,771
Net increase (decrease) in cash, cash equivalents and restricted cash
3,038
Cash, cash equivalents and restricted cash at beginning of period
17,276
Cash, cash equivalents and restricted cash at end of period
20,314
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from issuance ofdebt$20,000K Maturity of investments$39,750K Proceeds from issuance ofclass a common stock -...$491K Issuance of class a commonstock under the atm...$445K Proceeds from issuance ofclass a common stock -...$162K Sales of investments$2,505K Net cash provided byfinancing activities$19,771K Net cash provided byinvesting activities$14,329K Canceled cashflow$1,327K Canceled cashflow$27,926K Net increase(decrease) in cash, cash...$3,038K Canceled cashflow$31,062K Payments of debt issuancecosts$878K Tax withholding onsettlement of restricted...$419K Payments on finance leaseobligations$30K Accounts receivable-$4,387K Stock-based compensationexpense$4,033K Depreciation andamortization expense$3,252K Accounts payable$1,600K Inventory-$1,465K Noncash lease expense$1,218K Provision for excess &obsolete inventory$1,143K Accretion on investments-$351K Prepaid expenses andother current assets-$320K Noncash interestexpense$97K Other long-termliabilities$64K Other long-termassets-$64K Other-$34K Accrued expenses andother current...$28K Purchases of investments$27,076K Purchases of property andequipment$850K Net cash used inoperating activities-$31,062K Canceled cashflow$18,056K Net loss-$47,123K Deferred revenue-$1,864K Gain on revaluationof warrant...-$131K

RAPID MICRO BIOSYSTEMS, INC. (RPID)

RAPID MICRO BIOSYSTEMS, INC. (RPID)